Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic stroke

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Rathcke, Camilla Noelle ^a,b   Thomsen, Stine Brinkloev ^a   Linneberg, Allan ^c   Vestergaard, Henrik ^a,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; UNCLASSIFIED DRUG; YKL 40 PROTEIN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHITINASE 3 LIKE 1 GENE; DISEASE MARKER; DNA SEQUENCE; FEMALE; FOLLOW UP; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HOMOZYGOTE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOKINES; ADULT; FEMALE; GENOTYPE; HUMANS; LECTINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE;

EID: 84866615975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043498     Document Type: Article

References (36)

1. Rathcke CN, Vestergaard H, (2009) YKL-40-an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 8: 61-67.
2. Kucur M, Isman FK, Karadag B, Vural VA, Tavsanoglu S, (2007) Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis 18: 391-396.
3. Wang Y, Ripa RS, Johansen JS, Gabrielsen A, Steinbruchel DA, et al. (2008) YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand Cardiovasc J 42: 295-302.
4. Kastrup J, Johansen JS, Winkel P, Hansen JF, Hildebrandt P, et al. (2009) High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. Eur Heart J 30: 1066-1072.
5. Nojgaard C, Host NB, Christensen IJ, Poulsen SH, Egstrup K, et al. (2008) Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron Artery Dis 19: 257-263.
6. Rathcke CN, Raymond I, Kistorp C, Hildebrandt P, Faber J, et al. (2010) Low grade inflammation as measured by levels of YKL-40: Association with an increased overall and cardiovascular mortality rate in an elderly population. Int J Cardiol 143: 35-42.
7. Johansen JS, Bojesen SE, Tybjaerg-Hansen A, Mylin AK, Price PA, et al. (2010) Plasma YKL-40 and total and disease-specific mortality in the general population. Clin Chem 56: 1580-1591.
8. Kjaergaard AD, Bojesen SE, Johansen JS, Nordestgaard BG, (2010) Elevated plasma YKL-40 levels and ischemic stroke in the general population. Ann Neurol 68: 672-680.
9. Johansen JS, (2006) Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53: 172-209.
10. Boot RG, van Achterberg TA, van Aken BE, Renkema GH, Jacobs MJ, et al. (1999) Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 19: 687-694.
11. Rathcke CN, Holmkvist J, Husmoen LL, Hansen T, Pedersen O, et al. (2009) Association of polymorphisms of the CHI3L1 gene with asthma and atopy: a populations-based study of 6514 Danish adults. PLoS One 4: e6106.
12. Kruit A, Grutters JC, Ruven HJ, van Moorsel CC, van den Bosch JM, (2007) A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir Med 101: 1563-1571.
13. Ober C, Tan Z, Sun Y, Possick JD, Pan L, et al. (2008) Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 358: 1682-1691.
14. Sohn MH, Lee JH, Kim KW, Kim SW, Lee SH, et al. (2009) Genetic Variation in the Promoter Region of Chitinase 3-Like 1 (CHI3L1) is Associated with Atopy. Am J Respir Crit Care Med 179: 449-456.
15. Zheng JL, Lu L, Hu J, Zhang RY, Zhang Q, et al. (2011) Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population. Cytokine 54: 51-55.
16. Jorgensen T, (1987) Prevalence of gallstones in a Danish population. Am J Epidemiol 126: 912-921.
17. Rosenstock SJ, Jorgensen T, (1995) Prevalence and incidence of peptic ulcer disease in a Danish County-a prospective cohort study. Gut 36: 819-824.
18. Rosenstock S, Kay L, Rosenstock C, Andersen LP, Bonnevie O, et al. (1997) Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut 41: 169-176.
19. Rosenstock SJ, Jorgensen T, Andersen LP, Bonnevie O, (2000) Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health 28: 32-40.
20. Rowe DJ, Dawnay A, Watts GF, (1990) Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine. Ann Clin Biochem 27 (Pt 4) (): 297-312.
21. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, et al. (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223.
22. Raymond M, Rousset F, (1995) GENEPOP (Version 1.2): Population Genetics Software for Exact Tests and Ecumenicism. J Heredity 86: 248-249.
23. Rousset F, (2008) GENEPOP '007: a complete re-implementation of the GENEPOP software for Windows and Linux. Mol Ecol Resources 8: 103-106.
24. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M, (2003) The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 56: 124-130.
25. Rose G, McCartney P, Reid DD, (1977) Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 31: 42-48.
26. Johansen JS, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK, et al. (2008) High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Clin Exp Immunol 151: 260-266.
27. Hu FB, (2007) Obesity and mortality: watch your waist, not just your weight. Arch Intern Med 167: 875-876.
28. Ling H, Recklies AD, (2004) The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem J 380: 651-659.
29. Henningsen KM, Therkelsen SK, Johansen JS, Bruunsgaard H, Svendsen JH, (2009) Plasma YKL-40, a new biomarker for atrial fibrillation? Europace 11: 1032-1036.
30. Henningsen KM, Nilsson B, Johansen JS, Chen X, Pehrson S, et al. (2010) Plasma YKL-40 is elevated in patients with recurrent atrial fibrillation after catheter ablation. Inflamm Res 59: 463-469.
31. Zheng JL, Lu L, Hu J, Zhang RY, Zhang Q, et al. (2010) Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease. Atherosclerosis 210: 590-595.
32. Hedegaard A, Ripa RS, Johansen JS, Jorgensen E, Kastrup J, (2010) Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction. Scand J Clin Lab Invest 70: 80-86.
33. Robertson RP, Harmon J, Tran PO, Poitout V, (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 Suppl 1: S119-S124.
34. Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, et al. (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211: 589-595.
35. McCarthy MI, (2003) Growing evidence for diabetes susceptibility genes from genome scan data. Curr Diab Rep 3: 159-167.
36. Bojesen SE, Johansen JS, Nordestgaard BG, (2011) Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta 412: 709-712.